演讲者 |
| Helmut |
Albrecht |
President |
H2A Associates |
| Bo |
Allen |
President and CEO |
Versalion Pharmaceuticals, LLC |
| David |
Azad |
Managing Director |
Galen Partners |
| Sujit |
Basu |
Senior Director Formulation |
Dicerna Pharmaceuticals |
| Debra |
Bingham |
Partner |
Valeo Partners |
| Robert |
Bloder |
VP, Business Development |
Aveva Drug Delivery Systems |
| Christof |
Böhler, PhD |
CEO |
Pantec Biosolutions
|
| Josef |
Bossart |
Managing Director |
Bionumbers |
| Jones W. (Woody) |
Bryan, PhD |
Vice President of Business Development and Project Management |
Supernus Pharmaceuticals |
| Mahesh |
Chaubel |
Director, Global R&D |
Baxter |
| David |
Cipolla |
Senior Director, Pharmaceutical Sciences |
Aradigm Corporation |
| Michael |
Cucolo |
Director, Strategy Alliances and Transactions |
Bristol Myers Squibb |
| Tom |
Daschle |
Former United State Senator |
United States Senate |
| Neil |
Desai |
VP, Global Research and Development |
Abraxis Bioscience, LLC |
| John |
Fox |
Chief Development Officer |
Merrion Pharmaceuticals Ireland Limited |
| John |
Fraher |
Chief Commercial Officer |
Eurand |
| Brian |
Gabrio |
Business Development Director |
3M Company |
| Patrick |
Gallagher |
VP, Business Development |
Noven Pharmaceuticals |
| Danchen |
Gao |
Director, Intellectual Property Strategy
|
Abbott Laboratories
|
| Thomas |
Goetz |
Editor |
Wired |
| Philip |
Green |
Senior Director, Drug Delivery Devices |
Merck Bioventures |
| Balu |
Gupta |
Former Associate Vice President/Head, Global Immuno-Inflammation Patent Support and VP, Patent Estate Management |
sanofi-aventis US |
| Michael F. |
Haller, PhD |
Vice President, Alliance Management & Head, Drug Delivery Franchise |
Halozyme Therapeutics |
| Troy |
Harmon |
Vice President, Business Development |
Eurand |
| Tom |
Haverty |
VP, Merck Ventures and Early Biologics |
Merck Research Laboratories |
| Peter |
Hoffmann |
VP, New Technology Development |
Genzyme Pharmaceuticals |
| Keith |
Horspool |
VP, Pharmaceutics |
Boehringer Ingelheim |
| Robin |
Hwang |
Vice President, Head of Drug Delivery Devices |
Halozyme Therapeutics |
| Dean |
Kamen |
Founder |
DEKA Research |
| Manohar |
Katakam |
Director, New Products |
Pfizer |
| Peter |
Kramer |
President |
PK Consulting |
| Thomas |
Landh |
Director, Strategy and Sourcing |
Novo Nordisk |
| Tom |
Leonard |
Chief Scientific Officer |
Merrion Pharmaceuticals Ireland Limited |
| Andrea |
Leone Bay |
Vice President |
MannKind Corporation |
| Snehlata |
Mascarenhas |
Project Management Consultant-Drug Delivery |
Eli Lilly & Co. |
| Gerhard |
Mayer |
Director of Marketing |
Bayer HealthCare |
| David |
Monteith |
Senior Director, Drug Delivery & Life Cycle Development |
Merck & Co. |
| Dennis |
Nelsen |
VP, R&D, Worldwide Head of OTC Product Development |
Merck Consumer Care |
| Bob |
Nissen |
President |
Nissen Consulting Group, LLC |
| Peter |
Noymer |
VP, Product Research and Development |
Alexza Pharmaceuticals |
| Vickie |
O'Neill |
VP, Research and Technology Development, |
Upsher-Smith Laboratories |
| Riccardo |
Panicucci |
Global Head, Chemical & Pharmaceutical Profiling |
Novartis |
| Arundeep |
Pradhan |
Associate Vice President, Technology Transfer & Business Development |
Oregon Health & Science University |
| Julia |
Rashba-Step |
Senior Director, Novel Delivery Technologies |
Pfizer Biotherapeutics Research & Development |
| Anthony |
Recupero |
Senior Director, Business Development |
Eurand |
| Peter |
Richardson |
Chief Scientific Officer |
MannKind Corporation |
| Jonathan |
Rigby |
Vice President Business Development |
Zogenix |
| Mathias |
Romacker |
Principal Business Analyst |
Amgen Inc |
| Vik |
Seoni |
Vice President & Head of Business Development |
Elan Drug Technologies |
| Lee |
Shorter |
Director Pre Clinical Development |
GlaxoSmithKline Pharmaceuticals |
| Lior |
Shtram |
Director Technology Management |
Flextronics |
| Peter |
Staple |
President and CEO |
Corium |
| David |
Steinberg |
Managing Director |
Deutsche Bank |
| Philip |
Strassburger |
VP & Intellectual Property Counsel |
Purdue Pharma LP |
| Anand |
Subramony, Ph.D. |
Principal Fellow & Head Novel Delivery Technologies & Therapeutics (NDT) |
Novartis Institutes for BioMedical Research, Inc. |
| Mark |
Wilson |
Director, Collaboration Management, Europe |
GlaxoSmithKline |
| Brian |
Windsor |
SVP, Portfolio Company Management |
Emergent Technologies, Inc. |
| Lawrence |
Zaccaro |
Associate Director, Research & Development, Business Development |
Pfizer |
| Brett |
Zbar |
Partner |
Aisling Capital |
